Hera Health Solutions develops bioerodible drug delivery implants that release therapeutic agents over time, eliminating the need for painful removal procedures associated with traditional contraceptive methods. Their technology addresses the challenge of providing long-acting, safe, and effective contraception while minimizing patient discomfort and healthcare costs.
Funding
Funding not disclosed
Founders
Product
Problem
Current long-acting contraceptive arm implants require a removal procedure, which can be costly and painful for women. This can deter women from choosing this effective contraceptive method, leading to unintended pregnancies.
Solution
Hera Health Solutions is developing a bioerodible contraceptive arm implant, Eucontra™, designed to release contraceptive hormones over time and eliminate the need for surgical removal. The implant is made of biodegradable materials that safely break down in the body as the hormone is released, offering a convenient and effective long-term contraception option. This innovative approach aims to reduce patient discomfort, lower healthcare costs associated with removal procedures, and provide women with a more accessible and user-friendly contraceptive solution. Eucontra™ is currently undergoing trials and is not yet FDA approved.
Target Audience
The primary target audience is women seeking long-acting, reversible contraception, as well as healthcare providers looking for innovative and patient-friendly contraceptive options.
Features
- Bioerodible implant that degrades over time as the contraceptive hormone is released
- Eliminates the need for a separate removal procedure
- Aims to provide a safe and effective long-acting contraception solution